MIMIX
Vaxess Technologies, Inc.
Application Filed: 2016-09-23
Trademark Application Details
FOURTH EXTENSION - GRANTED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87181775 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Nicole Kinsley, |
| Attorney Docket Number | 31110.00014 |
| Law Office Assigned | L30 |
| Employee Name | LAW, CHRISTOPHER M |
Timeline
| 2016-09-23 | Application Filed |
| 2017-10-17 | Published for Opposition |
| 2017-12-12 | Location: INTENT TO USE SECTION |
| 2019-10-02 | Status: Live/Pending |
| 2019-10-04 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Vaxess Technologies, Inc. |
| Address | c/o Lab Central 700 Main Street Cambridge DE 02139 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceuticals, namely, pain relief medication and hormones for medical purposes; vaccines; immunotherapies for the treatment of cancer, autoimmune diseases or disorders, and allergies; drug delivery agents in the form of patches that provide transdermal delivery of the active ingredient for a wide range of pharmaceuticals; drug delivery agents in the form of polymers that facilitate the sustained release of a wide range of pharmaceuticals; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with vaccines; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with immunotherapies for the treatment of cancer, autoimmune diseases or disorders, and allergies; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with pain relief medication; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with hormones for medical purposes |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2016-09-27 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2016-09-28 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2016-12-29 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2016-12-31 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2016-12-31 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2016-12-31 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-01-23 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-01-23 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-01-23 | 9 TEME I:Incoming Correspondence |
| NON-FINAL ACTION WRITTEN | 2017-02-27 | 10 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2017-02-27 | 11 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-02-27 | 12 GNRN O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2017-03-01 | 13 DOCK D:Assigned to Examiner |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-08-11 | 14 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-08-11 | 15 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-08-12 | 16 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-09-06 | 17 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-09-27 | 18 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2017-10-17 | 19 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-10-17 | 20 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2017-12-12 | 21 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2018-03-06 | 22 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2018-03-06 | 23 EXT1 S: |
| EXTENSION 1 GRANTED | 2018-03-06 | 24 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-03-08 | 25 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2018-10-10 | 26 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2018-10-10 | 27 EXT2 S: |
| EXTENSION 2 GRANTED | 2018-10-10 | 28 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-10-12 | 29 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2019-03-13 | 30 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2019-03-13 | 31 EXT3 S: |
| EXTENSION 3 GRANTED | 2019-03-13 | 32 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-03-15 | 33 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2019-10-02 | 34 EEXT I:Incoming Correspondence |
| EXTENSION 4 FILED | 2019-10-02 | 35 EXT4 S: |
| EXTENSION 4 GRANTED | 2019-10-02 | 36 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-10-04 | 37 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2020-04-08 | 38 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2020-04-13 | 39 AITU A:Allowance for Publication |
| EXTENSION 5 FILED | 2020-04-08 | 40 EXT5 S: |
| EXTENSION 5 GRANTED | 2020-04-13 | 41 EX5G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-04-14 | 42 EXRA E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2021-01-18 | 43 ABN6 S: |
| ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 2021-01-19 | 44 MAB6 E:E-Mail |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 